Yoo Seung Ah, Sayo Marianne Isabel Abola, Lee Ji Hyun
Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seocho-gu, Seoul, Republic of Korea.
Department of Dermatology, East Avenue Medical Center, Quezon City, Metro Manila, Philippines.
Indian J Dermatol Venereol Leprol. 2025 Mar-Apr;91(2):152-157. doi: 10.25259/IJDVL_669_2023.
Background Several studies have reported that psoriasis has a positive correlation with type 2 diabetes mellitus (DM). Understanding the risk of psoriasis in diabetic patients is significant because it allows for early intervention and potential insights into the common pathways between the two conditions. Objectives We analysed the risk of psoriasis according to the estimated glomerular filtration rate (eGFR) and proteinuria level in DM patients using Korean population-based data. Methods This study was a retrospective cohort study using data collected from the country in the form of exploratory data analysis. A total of 927,234 participants diagnosed with DM were enrolled. Patients under the age of 20 with existing psoriasis or psoriasis developed within 1 year and missing data were excluded. The development of psoriasis was the primary outcome within a follow-up period of 7.83 ± 1.68 years. Results Of the 840,395 final participants, 28,010 (3.33%) patients developed psoriasis. In multivariate-adjusted Cox proportional hazards regression models, the DM patients with eGFR < 30 had a higher risk of psoriasis after adjustment (eGFR 60-90, hazard ratio [HR] 1 (Ref.); eGFR < 30, HR 1.173, 95% CI 1.089-1.264). In addition, there was an increased psoriatic risk of patients with DM and proteinuria after adjustment (negative, HR 1 (Ref.); 2+, HR 1.164, 95% CI 1.080-1.254; 3+, HR 1.433, 95% CI 1.273-1.613; 4+, HR 1.508, 95% CI 1.177-1.931). Limitations The severity of psoriasis was not measured since the occurrence of psoriasis was the outcome. Details of oral hypoglycaemic agents such as type and dose were not investigated. Conclusion This study showed that a decrease in eGFR and aggravation of proteinuria increase the risk of psoriasis in diabetic patients. Therefore, by using eGFR and proteinuria as predictive risk factors of psoriasis in DM patients, early and proactive treatment may play a vital role in managing diabetic patients.
背景 多项研究报告称,银屑病与2型糖尿病(DM)呈正相关。了解糖尿病患者患银屑病的风险具有重要意义,因为这有助于早期干预,并深入了解这两种疾病之间的共同发病机制。目的 我们使用韩国基于人群的数据,根据估计肾小球滤过率(eGFR)和蛋白尿水平分析糖尿病患者患银屑病的风险。方法 本研究是一项回顾性队列研究,采用以探索性数据分析形式从该国收集的数据。共纳入927234名诊断为糖尿病的参与者。排除20岁以下患有银屑病或在1年内发生银屑病的患者以及数据缺失的患者。银屑病的发生是7.83±1.68年随访期内的主要结局。结果 在840395名最终参与者中,28010名(3.33%)患者发生了银屑病。在多变量调整的Cox比例风险回归模型中,eGFR<30的糖尿病患者在调整后患银屑病的风险更高(eGFR 60 - 90,风险比[HR] 1(参照);eGFR<30,HR 1.173,95%置信区间1.089 - 1.264)。此外,调整后糖尿病合并蛋白尿患者的银屑病风险增加(阴性,HR 1(参照);2 +,HR 1.164,95%置信区间1.080 - 1.254;3 +,HR 1.433,95%置信区间1.273 - 1.613;4 +,HR 1.508,95%置信区间1.177 - 1.931)。局限性 由于银屑病的发生是结局,因此未测量银屑病的严重程度。未调查口服降糖药的类型和剂量等细节。结论 本研究表明,eGFR降低和蛋白尿加重会增加糖尿病患者患银屑病的风险。因此,将eGFR和蛋白尿作为糖尿病患者银屑病的预测风险因素,早期积极治疗可能在糖尿病患者管理中发挥至关重要的作用。